Oxford Immunotec Announces Release of New National Tuberculosis Test Data and Screening Grant for High Risk Patients on World TB Day
March 23, 2017 17:50 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Reports Fourth Quarter and Full Year 2016 Financial Results
February 28, 2017 16:05 ET
|
Oxford Immunotec
Fourth quarter revenue of $23.7 million, an increase of 41% compared to prior year periodFourth quarter Tuberculosis revenue of $20.4 million, an increase of 22% compared to prior year periodFourth...
Oxford Immunotec to Present at the Cowen and Company 37th Annual Health Care Conference
February 22, 2017 16:05 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...
Oxford Immunotec Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for February 28, 2017
February 14, 2017 16:05 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec to Present at the Leerink Partners 6th Annual Global Healthcare Conference
February 01, 2017 08:50 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...
Oxford Immunotec to Present at the 35th Annual J.P. Morgan Healthcare Conference
December 21, 2016 14:30 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...
Oxford Immunotec Announces New England Journal of Medicine Publication on Clinical Trial Results of Serological and Nucleic Acid Tests for Babesia in Blood Screening
December 08, 2016 07:00 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 08, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 17, 2016 09:15 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Ranked Among Deloitte’s 2016 Technology Fast 500™
November 16, 2016 13:15 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec to Present at the Jefferies 2016 London Healthcare Conference
November 02, 2016 14:19 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...